Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Teh

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Cancer Care|February 15, 2019
Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centreAlison Hiong, Karin A Thursky, Georgina Venn, et al.
Expert Review of Anti-Infective Therapy|September 9, 2016
The epidemiology of Clostridium difficile infection in patients with cancerAndrew I T Hebbard, Monica A Slavin, Caroline Reed, et al.
Critical Reviews in Oncology/Hematology|September 22, 2023
Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysisGemma K Reynolds, Beatrice Sim, Tim Spelman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 21, 2023
Drivers and barriers to COVID-19 vaccination in Australians with cancerChristie Allan, Amelia Hyatt, Amanda Appathurai, et al.
Frontiers in Immunology|October 30, 2020
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) VaccinesKatie L Flanagan, Emma Best, Nigel W Crawford, et al.
European Journal of Haematology|May 15, 2013
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxisGabrielle M Haeusler, Monica A Slavin, John F Seymour, et al.
Leukemia & Lymphoma|April 11, 2014
Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxisSenthil M Lingaratnam, Monica A Slavin, Karin A Thursky, et al.
Clinical & Translational Immunology|January 13, 2021
Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myelomaMarcel Doerflinger, Alexandra L Garnham, Saskia Freytag, et al.
Vaccine|March 4, 2026
Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapiesXia Wang, Cyra Patel, Ketaki Sharma, et al.
Frontiers in Immunology|October 21, 2017
Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune ProfilingBenjamin W Teh, Simon J Harrison, Cody Charles Allison, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Cancer Care|February 15, 2019
Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centreAlison Hiong, Karin A Thursky, Georgina Venn, et al.
Expert Review of Anti-Infective Therapy|September 9, 2016
The epidemiology of Clostridium difficile infection in patients with cancerAndrew I T Hebbard, Monica A Slavin, Caroline Reed, et al.
Critical Reviews in Oncology/Hematology|September 22, 2023
Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysisGemma K Reynolds, Beatrice Sim, Tim Spelman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 21, 2023
Drivers and barriers to COVID-19 vaccination in Australians with cancerChristie Allan, Amelia Hyatt, Amanda Appathurai, et al.
Frontiers in Immunology|October 30, 2020
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) VaccinesKatie L Flanagan, Emma Best, Nigel W Crawford, et al.
European Journal of Haematology|May 15, 2013
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxisGabrielle M Haeusler, Monica A Slavin, John F Seymour, et al.
Leukemia & Lymphoma|April 11, 2014
Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxisSenthil M Lingaratnam, Monica A Slavin, Karin A Thursky, et al.
Clinical & Translational Immunology|January 13, 2021
Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myelomaMarcel Doerflinger, Alexandra L Garnham, Saskia Freytag, et al.
Vaccine|March 4, 2026
Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapiesXia Wang, Cyra Patel, Ketaki Sharma, et al.
Frontiers in Immunology|October 21, 2017
Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune ProfilingBenjamin W Teh, Simon J Harrison, Cody Charles Allison, et al.
Pageof 7